Liang-Ge-San Decoction Ameliorates Acute Respiratory Distress Syndrome via Suppressing p38MAPK-NF-κB Signaling Pathway<sup>*</sup>

LI Quan; CHEN Juan; WANG Meng-meng; CAO Li-ping; ZHANG Wei; YANG Zhi-zhou; REN Yi; FENG Jing; HAN Xiao-qin; NIE Shi-nan; SUN Zhao-rui

doi:10.1007/s11655-024-3769-6

Your Location：

Home >

Browse articles >

Liang-Ge-San Decoction Ameliorates Acute Respiratory Distress Syndrome via Suppressing p38MAPK-NF-κB Signaling Pathway^*

Original Article | Updated：2025-07-11

- Liang-Ge-San Decoction Ameliorates Acute Respiratory Distress Syndrome via Suppressing p38MAPK-NF-κB Signaling Pathway^*
- Liang-Ge-San Decoction Ameliorates Acute Respiratory Distress Syndrome via Suppressing p38MAPK-NF-κB Signaling Pathway^*
- 中国结合医学杂志（英文版） 2025年31卷第7期页码：613-623
- Affiliations：
  
  1.Department of Intensive Care Unit, Suqian First Hospital, Suqian, Jiangsu Province (223800), China
  2.Department of Emergency Medicine, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing (210002), China
  3.Nanjing University of Chinese Medicine, Nanjing (210023), China
  4.Department of Emergency Medicine, the First School of Clinical Medicine, Southern Medical University, Nanjing (210002), China
- Author bio：
  
  Prof. SUN Zhao-rui, E-mail: sunzhr84@163.com
- Funds：
  
  the National Natural Science Foundation of China(82172182);the Natural Science Foundation of Jiangsu Province(BK20211136);the General Project of Science and Technology Development Fund of Nanjing Medical University(NMUB20210295);the Suqian Traditional Chinese Medicine Science and Technology Project(YB202212)
- DOI：10.1007/s11655-024-3769-6
  中图分类号：
- 录用日期：2024-05-25，
  
  网络出版日期：2024-12-05，
  
  纸质出版日期：2025-07
- Accepted：
Scan QR Code
Liang-Ge-San Decoction Ameliorates Acute Respiratory Distress Syndrome via Suppressing p38MAPK-NF-κB Signaling Pathway^*[J]. 中国结合医学杂志（英文版）, 2025,31(7):613-623.

LI Quan, CHEN Juan, WANG Meng-meng, et al. Liang-Ge-San Decoction Ameliorates Acute Respiratory Distress Syndrome via Suppressing p38MAPK-NF-κB Signaling Pathway^*[J]. Chinese journal of integrative medicine, 2025, 31(7): 613-623.
Liang-Ge-San Decoction Ameliorates Acute Respiratory Distress Syndrome via Suppressing p38MAPK-NF-κB Signaling Pathway^*[J]. 中国结合医学杂志（英文版）, 2025,31(7):613-623. DOI： 10.1007/s11655-024-3769-6.

LI Quan, CHEN Juan, WANG Meng-meng, et al. Liang-Ge-San Decoction Ameliorates Acute Respiratory Distress Syndrome via Suppressing p38MAPK-NF-κB Signaling Pathway^*[J]. Chinese journal of integrative medicine, 2025, 31(7): 613-623. DOI： 10.1007/s11655-024-3769-6.

摘要

Abstract

Objective:

To explore the potential effects and mechanisms of Liang-Ge-San (LGS) for the treatment of acute respiratory distress syndrome (ARDS) through network pharmacology analysis and to verify LGS activity through biological experiments.

Methods:

The key ingredients of LGS and related targets were obtained from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform. ARDS-related targets were selected from GeneCards and DisGeNET databases. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were performed using the Metascape Database. Molecular docking analysis was used to confirm the binding affinity of the core compounds with key therapeutic targets. Finally

the effects of LGS on key signaling pathways and biological processes were determined by

in vitro

and

in vivo

experiments.

Results:

A total of LGS-related targets and 496 ARDS-related targets were obtained from the databases. Network pharmacological analysis suggested that LGS could treat ARDS based on the following information: LGS ingredients luteolin

wogonin

and baicalein may be potential candidate agents. Mitogen-activated protein kinase 14 (MAPK14)

recombinant V-Rel reticuloendotheliosis viral oncogene homolog A (RELA)

and tumor necrosis factor alpha (TNF-α) may be potent

ial therapeutic targets. Reactive oxygen species metabolic process and the apoptotic signaling pathway were the main biological processes. The p38MAPK/NF-κB signaling pathway might be the key signaling pathway activated by LGS against ARDS. Moreover

molecular docking demonstrated that luteolin

wogonin

and baicalein had a good binding affinity with MAPK14

RELA

and TNFα.

In vitro

experiments

LGS inhibited the expression and entry of p38 and p65 into the nucleation in human bronchial epithelial cells (HBE) cells induced by LPS

inhibited the inflammatory response and oxidative stress response

and inhibited HBE cell apoptosis (

0.05 or

0.01).

In vivo

experiments

LGS improved lung injury caused by ligation and puncture

reduced inflammatory responses

and inhibited the activation of p38MAPK and p65 (

0.05 or

0.01).

Conclusion:

LGS could reduce reactive oxygen species and inflammatory cytokine production by inhibiting p38MAPK/NF-κB signaling pathway

thus reducing apoptosis and attenuating ARDS.

关键词

Keywords

references

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Network Pharmacology and in vitro Experimental Verification on Intervention of Oridonin on Non-Small Cell Lung Cancer

Therapeutic Mechanism of Kai Xin San on Alzheimer's Disease Based on Network Pharmacology and Experimental Validation

Network Pharmacology-Based Exploration of Synergistic Mechanism of Guanxin Ⅱ Formula (冠心Ⅱ号方) for Coronary Heart Disease

Brucea javanica Seed Oil Emulsion and Shengmai Injections Improve Peripheral Microcirculation in Treatment of Gastric Cancer

Mechanism of Asperosaponin Ⅵ Related to EGFR/MMP9/AKT/PI3K Pathway in Treatment of Rheumtoid Arthritis